share_log

Lake Street Initiates Coverage On Silk Road Medical With Buy Rating, Announces Price Target of $20

Lake Street Initiates Coverage On Silk Road Medical With Buy Rating, Announces Price Target of $20

Lake Street以買入評級啓動對絲路醫療的報道,宣佈目標股價爲20美元
Benzinga ·  01/04 00:45

Lake Street analyst Frank Takkinen initiates coverage on Silk Road Medical (NASDAQ:SILK) with a Buy rating and announces Price Target of $20.

湖街分析師弗蘭克·塔基寧以買入評級啓動了對絲綢之路醫療(納斯達克股票代碼:SILK)的報道,並宣佈目標股價爲20美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論